|
|
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date26 Nov 1976 |
|
Mechanism50S subunit inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date20 Feb 1959 |
|
MechanismGABAA receptor agonists |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date09 Jul 1954 |
100 Clinical Results associated with Parkedale Pharmaceuticals, Inc.
0 Patents (Medical) associated with Parkedale Pharmaceuticals, Inc.
100 Deals associated with Parkedale Pharmaceuticals, Inc.
100 Translational Medicine associated with Parkedale Pharmaceuticals, Inc.